[Form 4] Savers Value Village, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Mark T. Walsh, CEO and Director of Savers Value Village, Inc. (SVV), reported option exercise and an offsetting sale on 09/11/2025. He exercised 4,096 options with an exercise price of $1.41 per share, producing 4,096 shares acquired. Those same 4,096 shares were sold under a 10b5-1 plan adopted May 19, 2025, at a weighted-average sale price of $13.0174 per share, with trade executions ranging from $13.00 to $13.04. Following these transactions, the report shows Mr. Walsh beneficially owns 2,104,710 shares directly. The exercised options originated from an October 7, 2019 grant that fully vested on October 7, 2024; approximately 37% of the options were time-based and 63% performance-based.

Positive

• Transactions executed under a documented 10b5-1 plan (adopted May 19, 2025), which provides pre-specified trading parameters.
• Options fully vested from the October 7, 2019 grant (fully vested on October 7, 2024), with vesting breakdown disclosed (~37% time-based, ~63% performance-based).
• Full disclosure of sale pricing including weighted-average price ($13.0174) and execution range ($13.00 to $13.04) and offer to provide per-price execution details upon request.

Negative

• Insider sale of 4,096 shares was reported, which may be perceived negatively by some investors despite being under a 10b5-1 plan.
• After the reported sale, the filing lists zero beneficial ownership for the 4,096 shares sold (the report shows the sold shares no longer held), indicating a reduction in that tranche of holdings.

Insights

Securities/Equity Analyst

TL;DR: Insider exercised options and sold the same number of shares under a pre-established 10b5-1 plan; overall direct beneficial ownership remains material.

The filing documents a routine post-vesting exercise and contemporaneous sale executed pursuant to a 10b5-1 trading plan, with an exercise price of $1.41 and a weighted-average sale price of $13.0174 for 4,096 shares. The filing discloses full vesting of the October 2019 option grant as of October 7, 2024 and quantifies the split between time-based and performance-based options. From a market-impact perspective, the sizes reported are small relative to institutional blocks but meaningful for disclosure: the reporting person retains 2,104,710 shares of common stock after these transactions.

Corporate Governance Expert

TL;DR: Transaction follows an adopted 10b5-1 plan and documents vesting terms; disclosure appears complete and procedurally conforming.

The report includes the required explanatory information: adoption date of the 10b5-1 plan, weighted-average sale price and price range, and vesting schedule details for the 2019 option grant. Signature by attorney-in-fact is provided. The filing explains the composition of the option award (approx. 37% time-based, 63% performance-based) and the performance-based vesting linkage to IPO and further stock-price criteria. From a governance standpoint, the filing supplies the detail investors and regulators expect for insider transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Walsh Mark T.

(Last) (First) (Middle)

C/O SAVERS VALUE VILLAGE, INC.

11400 SE 6TH, SUITE 125

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Savers Value Village, Inc. [ SVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO & Director

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		M		4,096	A	$1.41	4,096	D
Common Stock	09/11/2025		S(1)		4,096	D	$13.0174(2)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Purchase)(3)	$1.41	09/11/2025		M			4,096	(4)	10/07/2029	Common Stock	4,096	$1.41	2,104,710(5)	D

Explanation of Responses:

1. The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on May 19, 2025.

2. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $13.00 to $13.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

3. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.

4. The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024.

5. Approximately 37% represents time-based options which vested in substantially equal annual installments over five years starting October 7, 2020 and approximately 63% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

Remarks:

	/s/ Richard Medway, attorney in fact	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Mark T. Walsh report on Form 4 for SVV?

The Form 4 reports that on 09/11/2025 Mr. Walsh exercised 4,096 options at $1.41 per share and sold the resulting 4,096 shares at a weighted-average price of $13.0174 per share.

Were the sales executed under a 10b5-1 trading plan for SVV?

Yes. The sale was executed pursuant to a 10b5-1 plan adopted by the reporting person on May 19, 2025.

How many SVV shares does Mark T. Walsh beneficially own after these transactions?

Following the reported transactions the Form 4 lists Mr. Walsh as beneficially owning 2,104,710 shares directly.

What were the vesting terms of the option grant related to these transactions?

The options were from an October 7, 2019 grant that vested in substantially equal annual installments over five years starting October 7, 2020 and were fully vested on October 7, 2024; ~37% were time-based and ~63% performance-based.

What was the weighted-average sale price and execution range reported?

The weighted-average sale price was $13.0174 per share, with executions ranging from $13.00 to $13.04.